Features, pricing, ratings, and pros and cons, compared head to head.
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial endpoint protection platform tool by 360 Security Group (Qihoo 360). Axiado AX3080 TCU is a commercial firmware & embedded security tool by Axiado Corporation. Compare features, ratings, integrations, and community reviews side by side to find the best endpoint protection platform fit for your security stack. Independent and vendor-neutral: we never sell rankings.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
360 High-Risk Vulnerability Immunization Tool V2.0
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
Enterprise security teams protecting high-value assets from supply-chain and firmware-level attacks will find the AX3080 TCU's hardware root of trust and anti-tamper design irreplaceable; this is one of the few tools that actually moves the attack surface below the OS. OCP DC-SCM compliance plus integrated HSM and side-channel attack protection give you forensic anchoring most endpoint platforms can't touch. Skip this if your priority is detecting lateral movement or hunting active threats post-breach; the AX3080 is preventive infrastructure, not a detection engine.
Tool that immunizes Windows systems against critical vulnerabilities
Hardware-based trusted control unit with integrated security functions
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs Axiado AX3080 TCU for your endpoint protection platform needs.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..
Axiado AX3080 TCU: Hardware-based trusted control unit with integrated security functions. built by Axiado Corporation. Core capabilities include Hardware Root of Trust integration, Baseboard Management Controller (BMC), Trusted Platform Module (TPM)..
Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.
360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Axiado AX3080 TCU differentiates with Hardware Root of Trust integration, Baseboard Management Controller (BMC), Trusted Platform Module (TPM).
360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Axiado AX3080 TCU is developed by Axiado Corporation. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.
360 High-Risk Vulnerability Immunization Tool V2.0 and Axiado AX3080 TCU serve similar Endpoint Protection Platform use cases: both cover System Security. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox